LON:BTG

BTG (BTG) Share Forecast, Price & News

GBX 840

0.00 (0.00%)

(As of 08/19/2019)

Add

Compare

Today's Range: 840
▼
840
50-Day Range: 840
▼
840
52-Week Range: 512.50
▼
853

Volume: 271,742 shs
Average Volume: 960,389 shs
Market Capitalization: £3.26 billion

P/E Ratio: 29.47
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive BTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

About BTG

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

May 16, 2022 | finance.yahoo.com

Brazil Coca-Cola bottler Solar Bebidas sees IPO resumption as soon as Q4 - Yahoo Finance

May 13, 2022 | stocknews.com

CX: 5 Top-Rated Stocks Under $5 to Buy This Month - StockNews.com

May 9, 2022 | nasdaq.com

Brazilian lender BTG Pactual posts record net profit, revenue - Nasdaq

May 9, 2022 | nasdaq.com

Brazilian lender BTG Pactual posts 72% net profit jump in Q1 - Nasdaq

May 8, 2022 | bloomberg.com

Chile's Proposed Mining Shakeup Falls Short in Convention Vote - Bloomberg

May 6, 2022 | bloomberg.com

Worldwide Pulp Shortage Raises Risk of Higher Tissue Prices - Bloomberg

May 6, 2022 | americanbankingnews.com

BTG (LON:BTG) Share Price Crosses Above 200 Day Moving Average of $840.00

May 4, 2022 | nasdaq.com

B2Gold (BTG) Q1 Earnings and Revenues Beat Estimates - Nasdaq

May 2, 2022 | nasdaq.com

Is B2Gold Corp (BTG) a Great Value Stock Right Now? - Nasdaq

April 28, 2022 | americanbankingnews.com

BTG (LON:BTG) Stock Price Passes Above Two Hundred Day Moving Average of $840.00

April 26, 2022 | nasdaq.com

B2Gold (BTG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Nasdaq

April 26, 2022 | forbes.com

How Heavy Are Russian Losses, And What Does It Mean For Their Offensive? - Forbes

April 22, 2022 | barrons.com

Brazil’s Stocks Are Up 30% This Year, but Bargains Can Be Had - Barron's

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:BTG
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.btgplc.com
Phone: +44-20-75750000
Fax: N/A
Employees: 1,631
Year Founded: N/A

Sales & Book Value

Annual Sales: £914.10 million
Price / Sales: 3.57
Cash Flow: GBX 90.80 per share
Price / Cash Flow: 9.25
Book Value: GBX 355.80 per share
Price / Book: 2.36

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.05
Quick Ratio: 2.19

Price-To-Earnings

Trailing P/E Ratio: 29.47
Forward P/E Ratio: 18.67
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 388,256,992
Free Float: N/A
Market Cap: £3.26 billion
Optionable: Optionable

Company Calendar

Last Earnings: 5/15/2018
Today: 5/16/2022

MarketRank^™

Overall MarketRank^™

0.99 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BTG.

4.9 Community Rank

Outperform Votes
BTG has received 619 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BTG has received 218 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
BTG has received 73.95% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about BTG and other stocks. Vote “Outperform” if you believe BTG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BTG will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
BTG does not currently pay a dividend.
Dividend Growth
BTG does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BTG insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of BTG is 29.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 9.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of BTG is 29.47, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 13.10.
Price to Book Value per Share Ratio
BTG has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

BTG (LON:BTG) Frequently Asked Questions

How were BTG's earnings last quarter?: BTG plc (LON:BTG) posted its earnings results on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, topping the consensus estimate of $29.80 by $3.10.
View BTG's earnings history.
Who are BTG's key executives?: BTG's management team includes the following people:
Dr. Louise Makin MA, Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director (Age 58)
Mr. Duncan Kennedy A.C.A., B.Sc., CFO & Director
Dr. Peter Stratford, Chief Technical Officer & Head of Innovation (Age 52)
Mr. Andy Burrows, VP of Corp. & Investor Relations
Dr. Paul Mussenden, Gen. Counsel, Head of Strategic Affairs & Company Sec.
Who are some of BTG's key competitors?: Some companies that are related to BTG include Abcam (ABC), Trillium Therapeutics (TRIL), Oxford Nanopore Technologies (ONT), Genus (GNS), Cronos Group (CRON), Concordia International (CXR), BELLUS Health (BLU), Biotest Aktiengesellschaft (BIO), MorphoSys (MOR), Ergomed (ERGO), PureTech Health (PRTC), Oxford Biomedica (OXB), Silence Therapeutics (SLN), Pfenex (PFNX) and Inventiva (IVA).
View all of BTG's competitors.
What other stocks do shareholders of BTG own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC), B2Gold (BTO), Serco Group (SRP), Tahoe Resources (TAHO) and Advanced Micro Devices (AMD).
What is BTG's stock symbol?: BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."
How do I buy shares of BTG?: Shares of BTG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is BTG's stock price today?: One share of BTG stock can currently be purchased for approximately GBX 840.
How much money does BTG make?: BTG has a market capitalization of £3.26 billion and generates £914.10 million in revenue each year.
How many employees does BTG have?: BTG employs 1,631 workers across the globe.
What is BTG's official website?: The official website for BTG is www.btgplc.com.
How can I contact BTG?: BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The company can be reached via phone at +44-20-75750000.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.